Edition:
United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

2.02USD
7 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.02
Open
$2.00
Day's High
$2.05
Day's Low
$2.00
Volume
4,922
Avg. Vol
34,425
52-wk High
$26.88
52-wk Low
$1.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.420
Jun '18 0.00 -7.482
Mar '18 0.00 -83.463
FY 2017 Dec '17 0.00 -3.404
Sep '17 0.00 -6.989
Jun '17 0.00 -4.925
Mar '17 0.00 -4.981
FY 2016 Dec '16 0.00 -4.240
Sep '16 0.00 -4.845
Jun '16 0.00 -4.062
Mar '16 0.00 -5.877
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 1 -0.34 -0.34 -0.34 -3.50
Quarter Ending Mar-19 1 -0.30 -0.30 -0.30 --
Year Ending Dec-18 1 -11.58 -11.58 -11.58 -15.25
Year Ending Dec-19 1 -1.09 -1.09 -1.09 -14.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.05 33.63
P/E High - Last 5 Yrs. 26.83 74.34 45.43
P/E Low - Last 5 Yrs. 26.83 20.27 24.43
Beta 3.34 0.93 0.90
Price to Sales (TTM) -- 8.48 5.77
Price to Book (MRQ) 2.80 4.09 5.12
Price to Tangible Book (MRQ) 2.80 5.49 6.54
Price to Cash Flow (TTM) -- 17.97 23.57
% Owned Institutions 18.71 18.32 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.77 1.49
Dividend Yield - 5 Year Avg -- 0.65 1.50
Dividend 5 Year Growth Rate -- 6.36 5.08
Payout Ratio(TTM) -- 22.35 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.11 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 6.32 5.80
Sales - 5 Yr. Growth Rate -- 3.01 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -21.24 45.72 21.03
EPS (TTM) vs TTM 1 Yr. Ago -15.83 -- --
EPS - 5 Yr. Growth Rate -- 3.93 10.79
Capital Spending - 5 Yr. Growth Rate -17.44 10.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.71 2.28
Current Ratio (MRQ) 5.89 2.22 3.11
LT Debt to Equity (MRQ) 3.32 41.60 11.47
Total Debt to Equity (MRQ) 5.62 52.31 15.63
Interest Coverage (TTM) -- 19.38 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.99 54.21
Gross Margin - 5 Yr. Avg. -- 55.45 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 15.59 11.83
Operating Margin (TTM) -- -1.06 4.90
Operating Margin - 5 Yr. Avg. -- 7.30 7.44
Pre-Tax Margin (TTM) -- -0.30 5.91
Pre-Tax Margin - 5 Yr. Avg. -- 6.47 7.89
Net Profit Margin (TTM) -- -2.23 2.16
Net Profit Margin - 5 Yr. Avg. -- 4.44 4.12
Effective Tax Rate (TTM) -- 15.97 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.76 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 16,212,381 898,926,015
Net Income/Employee (TTM) -658,405 1,434,241 106,550,787
Receivable Turnover (TTM) -- 5.51 5.94
Inventory Turnover (TTM) -- 4.48 3.62
Asset Turnover (TTM) 0.00 0.79 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.62 1.29 11.50
Return on Assets - 5 Yr. Avg. -118.83 4.50 12.67
Return on Investment (TTM) -83.17 9.63 15.02
Return on Investment - 5 Yr. Avg. -273.41 6.13 16.45
Return on Equity (TTM) -86.11 15.55 16.60
Return on Equity - 5 Yr. Avg. -337.83 9.64 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 40.00 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for InVivo Therapeutics Holdings Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.79%
# of Holders: 32
Total Shares Held: 539,273
3 Mo. Net Change: -165,450
# New Positions: 3
# Closed Positions: 8
# Increased Positions: 12
# Reduced Positions: 13
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.